Private company
CANTEX PHARMACEUTICALS, INC.
American pharmaceutical preparations company, incorporated in Delaware. Summary from the record
Last updated Oct 21, 2026.
Overview
Corporate structure
CANTEX PHARMACEUTICALS, INC. sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
- CANTEX PHARMACEUTICALS, INC. DE
- Chimerix (United States) Stake ยท Durham
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.
Calendar
Drug trials and FDA: recently
- Apr 30, 2026Phase 1/2 trial completed Phase 1/2 trial of Azeliragon 5 mg, Azeliragon 10 mg and others in Glioblastoma: primary completion Apr 30, 2026, no results posted yet (ClinicalTrials.gov NCT05635734).2
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar
Stakes it holds
CANTEX PHARMACEUTICALS, INC. has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).
- Chimerix (United States)SC 13G/A Feb 3, 20223
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3